Symposium 1 Pathological diagnosis and clinical management of lymphoproliferative disorders and indolent lymphomas in the era of WHO classification 2016

[SY1-1] Lymphoproliferative disorders and indolent lymphomas of B-cell origin

Elaine S. Jaffe (Hematopathology Section, Laboratory of Pathology, CCR, NCI, MD, USA)

Dr. Jaffe did her medical studies at Cornell University Medical College and the University of Pennsylvania. She has been Chief of the Hematopathology Section at the NCI since 1980. Dr. Jaffe is an author of more than 600 peer reviewed articles, 150 chapters and invited reviews and 38 Editorials. She is an Editor for the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. Science Watch named her among the 10 most highly cited researchers in clinical oncology, and she was included among the 400 most highly cited researchers in Biomedical Science worldwide between 1996 and 2011. Dr. Jaffe has held leadership positions in several major medical societies, including the American Society of Hematology, United States and Canadian Academy of Pathology and the Society for Hematopathology. Dr. Jaffe has served on 18 journal editorial boards. She was elected to the Institute of Medicine of the National Academies in 2008, and in 2013 was awarded the Stratton Medal from the American Society of Hematology. Dr Jaffe was invited to give the Henry Rappaport Memorial Lecture at the Lugano International Congress on Malignant Lymphoma in 2013. Dr. Jaffe received the 2016 Rous Whipple Award from the American Society of Investigative Pathology. Her clinical and investigational studies have been intertwined to enhance our understanding of the malignant lymphomas.